Nasdaq
$0.8344▼ 1.82%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $36.9MShares out 44.2M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
6- 9.14After-hours26.09.15 06:004Ownership#●●●
ELUTIA INC.
Michelle LeRoux Williams, an executive at Elutia Inc., filed a Form 4 report regarding changes in beneficial ownership of securities effective September 10, 2026. This filing documents the internal transaction and updates the status of insider holdings.…more
$0.8344-1.82%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.14After-hours26.09.15 06:004Ownership
ELUTIA INC.
Insider Matthew Ferguson of Elutia Inc. reported a change in beneficial ownership of securities as of September 10, 2026. This filing serves as an official disclosure of the insider's equity position change to the SEC.…more
$0.8344-1.82%vs prev closeView filingShare - 9.14After-hours26.09.15 06:004Ownership
ELUTIA INC.
C. Randal Mills, an insider at Elutia Inc., reported a change in beneficial ownership of company securities as of September 10, 2026, via SEC Form 4. This filing serves as the official disclosure of the insider's equity transaction.…more
$0.8344-1.82%vs prev closeView filingShare
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoAfter-hours26.10.23 05:05#●●●#●●●
Elutia to Report Third Quarter 2026 Financial Results
Elutia announced that it will release its third quarter 2026 financial results after the market close on November 5, 2026. The company will also host a conference call to discuss the quarterly performance with investors.…more
$0.8344-1.82%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.1After-hours26.10.02 05:45
●●●●●●●● ●●●●● ●●●●●●
Elutia announced it has received an $8 million escrow payment from Boston Scientific, ensuring the company is fully funded through 2029. This milestone allows the company to pursue the commercial launch of its NXT-41x product without the need for further equity offerings.…more
$0.8344-1.82%vs prev close - 9.10After-hours26.09.11 05:05
●●●●●●●● ●●●●● ●●●●●●
Elutia announced that its management team will present and host investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 15. The company will highlight its drug-eluting biomatrix technology aimed at addressing post-surgical infections.…more
$0.8344-1.82%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report